198 related articles for article (PubMed ID: 20659916)
21. Glucocorticoid-sparing effect of first-year anti-TNFα treatment in rheumatoid arthritis (CORPUS Cohort).
Duquenne C; Wendling D; Sibilia J; Job-Deslandre C; Guillevin L; Benichou J; Flipo RM; Guillemin F; Saraux A
Clin Exp Rheumatol; 2017; 35(4):638-646. PubMed ID: 28516872
[TBL] [Abstract][Full Text] [Related]
22. Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis.
Wasko MC; Dasgupta A; Hubert H; Fries JF; Ward MM
Arthritis Rheum; 2013 Feb; 65(2):334-42. PubMed ID: 23044791
[TBL] [Abstract][Full Text] [Related]
23. Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register.
Bergstra SA; Allaart CF; Ramiro S; Chopra A; Govind N; Silva C; Murphy EA; Landewé RBM
J Rheumatol; 2018 Oct; 45(10):1361-1366. PubMed ID: 29907672
[TBL] [Abstract][Full Text] [Related]
24. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
Curtis JR; Palmer JL; Reed GW; Greenberg J; Pappas DA; Harrold LR; Kremer JM
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1114-1124. PubMed ID: 32374918
[TBL] [Abstract][Full Text] [Related]
25. Mortality in rheumatoid arthritis patients treated with or without methotrexate.
Singer RB
J Insur Med; 2003; 35(3-4):144-9. PubMed ID: 14971085
[TBL] [Abstract][Full Text] [Related]
26. Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
Charles-Schoeman C; van der Heijde D; Burmester GR; Nash P; Zerbini CAF; Connell CA; Fan H; Kwok K; Bananis E; Fleischmann R
J Rheumatol; 2018 Feb; 45(2):177-187. PubMed ID: 29142036
[TBL] [Abstract][Full Text] [Related]
27. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis.
Miriovsky BJ; Michaud K; Thiele GM; O'Dell JR; Cannon GW; Kerr G; Richards JS; Johnson D; Caplan L; Reimold A; Hooker R; Mikuls TR
Ann Rheum Dis; 2010 Jul; 69(7):1292-7. PubMed ID: 20439294
[TBL] [Abstract][Full Text] [Related]
28. Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic Drugs.
Chester Wasko M; Dasgupta A; Ilse Sears G; Fries JF; Ward MM
Arthritis Care Res (Hoboken); 2016 May; 68(5):706-10. PubMed ID: 26415107
[TBL] [Abstract][Full Text] [Related]
29. Flares in Patients with Rheumatoid Arthritis after Total Hip and Total Knee Arthroplasty: Rates, Characteristics, and Risk Factors.
Goodman SM; Bykerk VP; DiCarlo E; Cummings RW; Donlin LT; Orange DE; Hoang A; Mirza S; McNamara M; Andersen K; Bartlett SJ; Szymonifka J; Figgie MP
J Rheumatol; 2018 May; 45(5):604-611. PubMed ID: 29545451
[TBL] [Abstract][Full Text] [Related]
30. Potential for Major Therapeutic Changes to Produce Significant Clinical Response Across a Broad Range of Disease Activity: An Observational Study of US Veterans With Rheumatoid Arthritis.
Sauer BC; Chen W; Shen J; Accortt NA; Collier DH; Cannon GW
Arthritis Care Res (Hoboken); 2021 Jul; 73(7):964-974. PubMed ID: 32166882
[TBL] [Abstract][Full Text] [Related]
31. Predictors of longterm changes in body mass index in rheumatoid arthritis.
Baker JF; Cannon GW; Ibrahim S; Haroldsen C; Caplan L; Mikuls TR
J Rheumatol; 2015 Jun; 42(6):920-7. PubMed ID: 25834210
[TBL] [Abstract][Full Text] [Related]
32. The positive influence of methotrexate on the mortality of patients with rheumatoid arthritis is partly independent of its effect on disease activity: results of a re-evaluation 18 years after baseline.
Krause D; Gabriel B; Herborn G; Braun J; Rau R
Clin Exp Rheumatol; 2014; 32(3):395-400. PubMed ID: 24773941
[TBL] [Abstract][Full Text] [Related]
33. The rapid kinetics of optimal treatment with subcutaneous methotrexate in early inflammatory arthritis: an observational study.
O'Connor A; Thorne C; Kang H; Tin D; Pope JE
BMC Musculoskelet Disord; 2016 Aug; 17(1):364. PubMed ID: 27558249
[TBL] [Abstract][Full Text] [Related]
34. Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis.
George MD; Sauer BC; Teng CC; Cannon GW; England BR; Kerr GS; Mikuls TR; Baker JF
J Rheumatol; 2019 Apr; 46(4):343-350. PubMed ID: 30275262
[TBL] [Abstract][Full Text] [Related]
35. Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: Results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registry.
Jung SM; Kwok SK; Ju JH; Lee SW; Song JJ; Yoon CH; Park YB; Park SH
PLoS One; 2018; 13(10):e0205651. PubMed ID: 30325962
[TBL] [Abstract][Full Text] [Related]
36. Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time.
Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
RMD Open; 2019; 5(1):e000836. PubMed ID: 30740244
[TBL] [Abstract][Full Text] [Related]
37. Influence of demographic and clinical factors on the mortality rate of a rheumatoid arthritis cohort: A 20-year survival study.
Abasolo L; Ivorra-Cortes J; Leon L; Jover JA; Fernandez-Gutierrez B; Rodriguez-Rodriguez L
Semin Arthritis Rheum; 2016 Apr; 45(5):533-8. PubMed ID: 26639031
[TBL] [Abstract][Full Text] [Related]
38. Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study.
Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YB; Han KH; Lee SW
Mod Rheumatol; 2020 Jan; 30(1):70-77. PubMed ID: 30557057
[No Abstract] [Full Text] [Related]
39. Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.
Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
Arthritis Rheumatol; 2017 Aug; 69(8):1566-1575. PubMed ID: 28425173
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis.
del Rincón I; Battafarano DF; Restrepo JF; Erikson JM; Escalante A
Arthritis Rheumatol; 2014 Feb; 66(2):264-72. PubMed ID: 24504798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
